Biologics Market
According to Intent Market Research, the Biologics Market is expected to grow from USD 374.6 billion in 2023 at a CAGR of 9.1% to touch USD 689.6 billion by 2030. The Biologics Market is dominated by key players such as Roche Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Eli Lilly, AstraZeneca, and Sanofi.